摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3R,4R,5R)-2-((1R,2S)-1-(benzyloxycarbonylamino)-2-hydroxybut-3-enyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diethanoate | 1043512-61-3

中文名称
——
中文别名
——
英文名称
(2R,3R,4R,5R)-2-((1R,2S)-1-(benzyloxycarbonylamino)-2-hydroxybut-3-enyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diethanoate
英文别名
[(2R,3R,4R,5R)-4-acetyloxy-2-[(1R,2S)-2-hydroxy-1-(phenylmethoxycarbonylamino)but-3-enyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
(2R,3R,4R,5R)-2-((1R,2S)-1-(benzyloxycarbonylamino)-2-hydroxybut-3-enyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diethanoate化学式
CAS
1043512-61-3
化学式
C25H29N3O10
mdl
——
分子量
531.519
InChiKey
VPLQBIALPNZCSS-CFPLAWGXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    38
  • 可旋转键数:
    12
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    170
  • 氢给体数:
    3
  • 氢受体数:
    10

反应信息

  • 作为反应物:
    描述:
    (2R,3R,4R,5R)-2-((1R,2S)-1-(benzyloxycarbonylamino)-2-hydroxybut-3-enyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diethanoate叔丁基二甲基氯硅烷咪唑4-二甲氨基吡啶 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以78%的产率得到(2R,3R,4R,5R)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-5-((5S,6S)-8,8,9,9-tetramethyl-3-oxo-1-phenyl-6-vinyl-2,7-dioxa-4-aza-8-siladecan-5-yl)tetrahydrofuran-3,4-diyl diethanoate
    参考文献:
    名称:
    合成霉素的研究:胸腺嘧啶核糖核苷衍生物的立体选择性路线。
    摘要:
    The ezomycins are Streptomyces-derived antifungal natural products, belonging to the complex peptidyl nucleoside family of antibiotics. Employing D-serine as a chiral platform, we report herein a novel synthetic route to the bicyclic octosyl nucleoside core of the ezomycins. A key step in the sequence involved a stereoselective 6-exo-trig oxymercuration-oxidation of a strategic delta-hydroxy alkene derivative, toward construction of the trans-fused furopyran ring system as present in the target products. In contrast to the known carbohydrate-based synthetic routes to the above furopyranyl fragment, the present amino acid chiral template approach is expected to offer a more flexible pathway toward potential SAR-targeted structural/stereochemical modifications of this central bicyclic nucleoside component of the ezomycins.
    DOI:
    10.1021/jo801050r
  • 作为产物:
    描述:
    溶剂黄146 作用下, 以 甲醇 为溶剂, 以0.590 g的产率得到(2R,3R,4R,5R)-2-((1R,2S)-1-(benzyloxycarbonylamino)-2-hydroxybut-3-enyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diethanoate
    参考文献:
    名称:
    合成霉素的研究:胸腺嘧啶核糖核苷衍生物的立体选择性路线。
    摘要:
    The ezomycins are Streptomyces-derived antifungal natural products, belonging to the complex peptidyl nucleoside family of antibiotics. Employing D-serine as a chiral platform, we report herein a novel synthetic route to the bicyclic octosyl nucleoside core of the ezomycins. A key step in the sequence involved a stereoselective 6-exo-trig oxymercuration-oxidation of a strategic delta-hydroxy alkene derivative, toward construction of the trans-fused furopyran ring system as present in the target products. In contrast to the known carbohydrate-based synthetic routes to the above furopyranyl fragment, the present amino acid chiral template approach is expected to offer a more flexible pathway toward potential SAR-targeted structural/stereochemical modifications of this central bicyclic nucleoside component of the ezomycins.
    DOI:
    10.1021/jo801050r
点击查看最新优质反应信息